This federal contract award to Insmed Inc., a global biopharmaceutical company, is for the delivery of ARIKAYCE (amikacin) 590mg/8.4ml, a medication used to treat nontuberculous mycobacterial lung infections. The contract, awarded by the U.S. Department of Veterans Affairs (VA), is a firm fixed-price delivery order with a ceiling value of $10,105.40 and an ultimate completion date of May 29, 2025. Insmed has established itself as a key provider of specialized pharmaceutical solutions to the...
This is a firm-fixed-price delivery order contract awarded by the Veterans Integrated Service Network 5 (VISN 5), a civilian agency within the U.S. Department of Veterans Affairs. The contract is for the pharmaceutical product Belzutifan (Welireg) 40 mg, a cancer treatment drug manufactured by Merck Sharp & Dohme LLC, doing business as Merck. The contract has a ceiling value of $22,051.39 and an ultimate completion date of June 6, 2025. Merck is the prime contractor, and there is no...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 issued a $15,442.08 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) to Insmed Incorporated for an emergency supply of ARIKAYCE (AMIKACIN LIPOSOME) INHALATION SUSPENSION 28 day packs. As the prime contractor, Insmed will deliver the liposomal amikacin inhalation medication to aid in the treatment of nontuberculous mycobacterial lung infections...
This is a delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The $19,964.86 firm-fixed price contract is for the supply of the drug belzutifan (Welireg) 40 mg, which is used for cancer treatment. This order is placed under Merck's Federal Supply Schedule (FSS) contract for pharmaceuticals and drugs. The contract has an ultimate completion date of October 9, 2024. Merck is a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IMFINZI 120 MG/2.4 ML VIAL 2.4ML, a medical product, with a ceiling value of $6,344.80. The contract has a completion date of February 24, 2025 and was awarded on January 31, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) between...
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Actelion Pharmaceuticals US, Inc., a large pharmaceutical manufacturer, to provide the drug Uptravi. The contract has a ceiling value of $76,829.76 and an ultimate completion date of December 19, 2019. It was awarded on January 12, 2018 under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The contract does not have a small business set-aside designation....
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INBRIJA 42 MG INHALATION CAP 60S, a specialty pharmaceutical product, with a total ceiling value of $3,882.72 and a completion date of January 14, 2025. The contract is a Firm Fixed Price arrangement and was not set aside for any specific business type....
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,941.36 firm fixed-price delivery order is for the pharmaceutical product INBRIJA 42 MG INHALATION CAP 60S. The contract has an ultimate completion date of January 27, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award was made by the U.S. Department of Veterans Affairs (VA) to Actelion Pharmaceuticals US, Inc., a for-profit pharmaceutical manufacturer. The $81,739.77 firm fixed-price delivery order is for the supply of Ventavis (iloprost) 10 mcg/mL inhalation solution, an oral medication used to treat pulmonary arterial hypertension. The contract is part of a larger Indefinite Delivery Vehicle (IDV) under the VA's Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $26,588.20 firm-fixed-price contract is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a specialty medication, to support federal healthcare programs. The contract has an ultimate completion date of January 6, 2025 and was awarded on December 12, 2024. No set-aside requirements were used for this contract. AmerisourceBergen holds a broader...